Impaired insulin signaling, for instance in diabetes mellitus, increases the risk of epilepsy (Verrotti et al., 2008; Ramakrishnan and Appleton, 2012) and cognitive disabilities (Seaquist, 2010; Kullmann et al., 2016). Here, INS is linked to diabetes mellitus.